Concepedia

Simon Doss-Gollin

SD

Statistics

Publications

10

Citations

334

H-Index

10

Active since

2021

Affiliations

Boston Children's Hospital(Current)

Harvard University

Broad Institute

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Simon Doss-Gollin is an author at Boston Children's Hospital specializing in infectious diseases, vaccinology, and vaccine immunology.

ORCID

Publications per year

2021–2023

10

Publications

10

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara et al. · Science Translational Medicine · 2022 · 110 citations

, , +17

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.

Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara et al. · PubMed · 2022 · 69 citations · Full text

, , +17

Evolution of Bacterial Cross-Resistance to Lytic Phages and Albicidin Antibiotic

Kaitlyn E. Kortright, Simon Doss-Gollin, Benjamin K. Chan et al. · Frontiers in Microbiology · 2021 · 36 citations · Full text

, , +17

CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns

Simon D. van Haren, Gabriel Kristian Pedersen, Azad Kumar et al. · Nature Communications · 2022 · 30 citations · Full text

, , +17

Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen

Simon Doss-Gollin, Sanya Thomas, Byron Brook et al. · npj Vaccines · 2023 · 22 citations · Full text

, , +17

1–5 of 10